Aclaris Therapeutics, Inc. (ACRS) Social Stream



Aclaris Therapeutics, Inc. (ACRS): $18.80

0.73 (+4.04%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Aclaris Therapeutics Inc (ACRS) Price Targets From Analysts

Use the tables below to see what analysts covering Aclaris Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
5 $50 $26 $34.8 $18.16 91.63%

The Trend in the Analyst Price Target


Over the past 85 days, ACRS's average price target has gone up $2.05.

Over the past 20 months, ACRS's average upside potential has been 45.61%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-08 5 50 26.0 34.80 16.84 106.65%
2021-09-04 5 50 26.0 34.80 17.34 100.69%
2021-08-28 5 50 26.0 34.80 15.69 121.8%
2021-07-19 5 50 26.0 34.20 14.20 140.85%
2021-07-17 5 50 26.0 34.20 14.49 136.02%
2021-07-10 5 50 26.0 34.20 17.59 94.43%
2021-07-03 5 50 26.0 34.20 17.07 100.35%
2021-06-15 4 40 26.0 32.75 17.81 83.89%
2021-06-13 4 40 26.0 32.75 18.38 78.18%
2021-06-05 4 40 26.0 32.75 21.73 50.71%
2021-05-19 4 40 26.0 32.75 22.97 42.58%
2021-04-26 4 40 24.0 32.00 26.06 22.79%
2021-04-25 4 40 24.0 32.00 26.71 19.81%
2021-04-17 3 38 24.0 29.33 26.68 9.93%
2021-03-25 3 30 24.0 26.67 23.97 11.26%
2021-03-20 3 30 24.0 26.67 26.79 -0.45%
2021-03-13 3 30 24.0 26.67 25.21 5.79%
2021-03-05 3 30 24.0 26.67 21.31 25.15%
2021-02-02 3 30 21.0 25.00 20.73 20.6%
2021-01-30 3 24 15.0 20.00 20.75 -3.61%
2021-01-23 3 24 15.0 20.00 18.22 9.77%
2021-01-16 3 7 4.5 5.83 5.88 -0.85%
2021-01-09 3 7 4.5 5.83 6.19 -5.82%
2021-01-02 3 7 4.5 5.83 6.47 -9.89%
2020-12-09 3 5 4.5 4.83 3.69 30.89%
2020-12-07 3 5 4.5 4.83 4.10 17.8%
2020-11-28 3 5 4.5 4.83 3.32 45.48%
2020-11-04 3 5 4.5 4.83 3.95 22.28%
2020-07-05 3 5 3.5 4.50 NA NA%
2020-01-04 4 8 3.5 5.38 NA NA%

ACRS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.25 3 3 0 0 0 6

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • ACRS has a less variance in analysts' estimates than 12.83% of all US stocks.
  • The upside potential (average analyst target price relative to current price) of ACRS is greater than 80.66% of all US stocks.
  • Aclaris Therapeutics Inc's average analyst price target is higher than 75.09% of stocks in the small market cap category.
  • The number of analysts covering the stock of ACRS is higher than 69.14% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Aclaris Therapeutics Inc are RIOT, SURF and SELB.

Is ACRS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.5771 seconds.